Circulation, Vol 71, 234-243, Copyright © 1985 by American Heart Association
RO Cannon 3d, DR Rosing, BJ Maron, MB Leon, RO Bonow, RM Watson and SE Epstein
To study the mechanism and hemodynamic significance of myocardial ischemia
in hypertrophic cardiomyopathy, 20 patients (nine with resting left
ventricular outflow tract obstruction greater than or equal to 30 mm Hg)
with a history of angina pectoris and angiographically normal coronary
arteries underwent a pacing study with measurement of great cardiac vein
flow, lactate and oxygen content, and left ventricular filling pressure.
Compared with 28 control subjects without hypertrophic cardiomyopathy,
their resting coronary blood flow was higher (91 +/- 27 vs 66 +/- 17
ml/min; p less than .001) and their coronary resistance was lower (1.13 +/-
0.38 vs 1.55 +/- 0.45 mm Hg/ml/min; p less than .001). Left ventricular
end-diastolic pressure (16 +/- 6 vs 11 +/- 3 mm Hg; p less than .001) and
pulmonary arterial wedge pressure (13 +/- 5 vs 7 +/- 3 mm Hg; p less than
.001) were significantly higher in patients with hypertrophic
cardiomyopathy. During pacing, coronary flow rose in both groups, although
coronary and myocardial hemodynamics differed greatly. In contrast to the
linear increase in flow in control subjects up to heart rate of 150
beats/min (66 +/- 17 to 125 +/- 28 ml/min), patients with hypertrophic
cardiomyopathy demonstrated an initial rise in flow to 133 +/- 31 ml/min at
an intermediate heart rate of 130 beats/min. At this point, 12 of 20
patients developed their typical chest pain. With continued pacing to a
heart rate of 150 beats/min, mean coronary flow fell to 114 +/- 29 ml/min
(p less than .002), with 18 of 20 patients experiencing their typical chest
pain and metabolic evidence of myocardial ischemia. This fall in coronary
flow was associated with a substantial rise in left ventricular
end-diastolic pressure (30 +/- 9 mm Hg immediately after peak pacing). In
the 14 patients whose coronary flow actually fell from intermediate to peak
pacing, the rise in left ventricular end- diastolic pressure in the same
interval was greater than that of the six patients whose flow remained
unchanged or increased (11 +/- 8 vs 2 +/- 2 mm Hg; p less than .01). In
addition, despite metabolic and hemodynamic evidence of myocardial
ischemia, the arteriovenous O2 difference actually narrowed at peak pacing.
Thus most patients with hypertrophic cardiomyopathy achieved maximum
coronary vasodilation and flow at modest increases in heart rate. Elevation
in left ventricular filling pressure, probably related to ischemia-induced
changes in ventricular compliance, was associated with a decline in
coronary flow.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures
This article has been cited by other articles:
![]() |
P. Knaapen, T. Germans, P. G. Camici, O. E. Rimoldi, F. J. ten Cate, J. M. ten Berg, P. A. Dijkmans, R. Boellaard, W. G. van Dockum, M. J. W. Gotte, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H986 - H993. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography Heart, October 1, 2007; 93(10): 1204 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P. G. Camici Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1043 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kido, N. Hasebe, Y. Ishii, and K. Kikuchi Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1064 - H1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Thaman, J R Gimeno, R T Murphy, T Kubo, B Sachdev, J Mogensen, P M Elliott, and W J McKenna Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy Heart, July 1, 2005; 91(7): 920 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Bestetti, H. A.R. Corbucci, L. D. Fornitano, M. F. Godoy, P. M. Cury, D. Villafanha, D. A. Santana, M. J.F. Soares, and D. M. Braile Angina-Like Chest Pain and Syncope as the Clinical Presentation of Left Ventricular Endomyocardial Fibrosis: A Case Report Angiology, May 1, 2005; 56(3): 339 - 342. [Abstract] [PDF] |
||||
![]() |
R. Thaman, J. R. Gimeno, S. Reith, M. T. T. Esteban, G. Limongelli, R. T. Murphy, B. Mist, W. J. McKenna, and P. M. Elliott Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy J. Am. Coll. Cardiol., July 21, 2004; 44(2): 398 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sorajja, S. R. Ommen, R. A. Nishimura, B. J. Gersh, P. B. Berger, and A. J. Tajik Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease Circulation, November 11, 2003; 108(19): 2342 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Isobe, H. Izawa, Y. Takeichi, M. Nonokawa, M. Nanasato, A. Ando, K. Kato, M. Ikeda, T. Murohara, and M. Yokota Relationship Between Exercise-Induced Myocardial Ischemia and Reduced Left Ventricular Distensibility in Patients with Nonobstructive Hypertrophic Cardiomyopathy J. Nucl. Med., November 1, 2003; 44(11): 1717 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P. G. Camici Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy N. Engl. J. Med., September 11, 2003; 349(11): 1027 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izawa, M. Iwase, Y. Takeichi, F. Somura, K. Nagata, T. Nishizawa, A. Noda, T. Murohara, and M. Yokota Effect of Nicorandil on Left Ventricular End-Diastolic Pressure During Exercise in Patients with Hypertrophic Cardiomyopathy Eur. Heart J., July 2, 2003; 24(14): 1340 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction Ann. Thorac. Surg., February 1, 2003; 75(2): 620 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Maron, I. Olivotto, S. Betocchi, S. A. Casey, J. R. Lesser, M. A. Losi, F. Cecchi, and B. J. Maron Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy N. Engl. J. Med., January 23, 2003; 348(4): 295 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sipola, K. Lauerma, M. Husso-Saastamoinen, J. T. Kuikka, E. Vanninen, T. Laitinen, H. Manninen, P. Niemi, K. Peuhkurinen, P. Jaaskelainen, et al. First-Pass MR Imaging in the Assessment of Perfusion Impairment in Patients with Hypertrophic Cardiomyopathy and the Asp175Asn Mutation of the {alpha}-Tropomyosin Gene Radiology, January 1, 2003; 226(1): 129 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ciampi, S. Betocchi, R. Lombardi, F. Manganelli, G. Storto, M. A. Losi, E. Pezzella, F. Finizio, A. Cuocolo, and M. Chiariello Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., July 17, 2002; 40(2): 278 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, K. Sakamoto, T. Yamano, M. Kikkawa, K. Zen, T. Hikosaka, T. Kubota, A. Azuma, and T. Nishimura Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1657 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fananapazir, S. A. Mohiddin, and J. Shih Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply J. Am. Coll. Cardiol., September 1, 2001; 38(3): 922 - 922. [Full Text] [PDF] |
||||
![]() |
F. Somura, H. Izawa, M. Iwase, Y. Takeichi, R. Ishiki, T. Nishizawa, A. Noda, K. Nagata, Y. Yamada, and M. Yokota Reduced Myocardial Sarcoplasmic Reticulum Ca2+-ATPase mRNA Expression and Biphasic Force-Frequency Relations in Patients With Hypertrophic Cardiomyopathy Circulation, August 7, 2001; 104(6): 658 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeichi, M. Yokota, M. Iwase, H. Izawa, T. Nishizawa, R. Ishiki, F. Somura, K. Nagata, S. Isobe, and A. Noda Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., August 1, 2001; 38(2): 335 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mohiddin, D. Begley, J. Shih, and L. Fananapazir Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kodama, Y. Shigematsu, M. Hamada, K. Hiwada, Y. Kazatani, K. Matsuzaki, and E. Murakami The Effect of Coronary Vasospasm on the Direction of ST-Segment Deviation in Patients With Both Hypertrophic Cardiomyopathy and Vasospastic Angina Chest, May 1, 2000; 117(5): 1300 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
P P. Dimitrow, M Krzanowski, R Nizankowski, A Szczeklik, and J S Dubiel Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy Heart, March 1, 2000; 83(3): 262 - 266. [Abstract] [Full Text] |
||||
![]() |
J. Shirani, R. Pick, W. C. Roberts, and B. J. Maron Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death J. Am. Coll. Cardiol., January 1, 2000; 35(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kawada, H. Sakuma, T. Yamakado, K. Takeda, N. Isaka, T. Nakano, and C. B. Higgins Hypertrophic Cardiomyopathy: MR Measurement of Coronary Blood Flow and Vasodilator Flow Reserve in Patients and Healthy Subjects Radiology, April 1, 1999; 211(1): 129 - 135. [Abstract] [Full Text] |
||||
![]() |
T. Akasaka, K. Yoshida, T. Hozumi, T. Takagi, S. Kaji, T. Kawamoto, Y. Ueda, Y. Okada, S. Morioka, and J. Yoshikawa Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1923 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshida, H. Ikeda, T. Wada, A. Matsumoto, S. Maki, A. Muro, A. Shibata, and T. Imaizumi Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1938 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yetman, R. M. Hamilton, L. N. Benson, and B. W. McCrindle Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1943 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hozumi, K. Yoshida, T. Akasaka, Y. Asami, Y. Ogata, T. Takagi, S. Kaji, T. Kawamoto, Y. Ueda, and S. Morioka Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: Comparison with invasive technique J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1251 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yetman, B. W. McCrindle, C. MacDonald, R. M. Freedom, and R. Gow Myocardial Bridging in Children with Hypertrophic Cardiomyopathy -- A Risk Factor for Sudden Death N. Engl. J. Med., October 22, 1998; 339(17): 1201 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hamada, Y. Kazatani, K. Matsuzaki, E. Murakami, Y. Shigematsu, K. Hiwada, and K. Kodama Clinical Characteristics in Japanese Patients with Coexistent Hypertrophic Cardiomyopathy and Coronary Vasospasm Angiology, September 1, 1998; 49(9): 849 - 855. [Abstract] [PDF] |
||||
![]() |
Y Okajima, Y Tanabe, M Takayanagi, and H Aotsuka A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) Heart, September 1, 1998; 80(3): 292 - 295. [Abstract] [Full Text] |
||||
![]() |
T. Hirayama, K. Marumoto, H. Okayama, T. Iwata, and M. Suzuki Paroxysmal Atrial Fibrillation as a Cause of Potentially Lethal Ventricular Arrhythmia with Myocardial Ischemia in Hypertrophic Cardiomyopathy: A Case Report Angiology, August 1, 1998; 49(8): 653 - 657. [Abstract] [PDF] |
||||
![]() |
H. Izawa, M. Yokota, Y. Takeichi, M. Inagaki, K. Nagata, M. Iwase, and T. Sobue Adrenergic Control of the Force-Frequency and Relaxation-Frequency Relations in Patients With Hypertrophic Cardiomyopathy Circulation, November 4, 1997; 96(9): 2959 - 2968. [Abstract] [Full Text] |
||||
![]() |
T. Akasaka, K. Yoshida, A. Yamamuro, T. Hozumi, T. Takagi, S. Morioka, and J. Yoshikawa Phasic Coronary Flow Characteristics in Patients With Constrictive Pericarditis : Comparison With Restrictive Cardiomyopathy Circulation, September 16, 1997; 96(6): 1874 - 1881. [Abstract] [Full Text] |
||||
![]() |
J. J. Allan, R. Paz, P. A. Tunick, and I. Kronzon Ethanol and Hypertrophic Cardiomyopathy N. Engl. J. Med., March 20, 1997; 336(12): 878 - 878. [Full Text] |
||||
![]() |
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF] |
||||
![]() |
E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text] |
||||
![]() |
R. D. Berger, M. R. Wolff, J. H. Anderson, and D. A. Kass Role of Atrial Contraction in Diastolic Pressure Elevation Induced by Rapid Pacing of Hypertrophied Canine Ventricle Circ. Res., July 1, 1995; 77(1): 163 - 173. [Abstract] [Full Text] |
||||
![]() |
G. Vassalli, P. Kaufmann, B. Villari, M. Jakob, H. Boj, W. Kiowski, and O. M. Hess Reduced Epicardial Coronary Vasodilator Capacity in Patients With Left Ventricular Hypertrophy Circulation, June 15, 1995; 91(12): 2916 - 2923. [Abstract] [Full Text] |
||||
![]() |
G. J. Magarian, R. Palac, and S. Reinhart Syndrome of Diminished Vasodilator Reserve of the Coronary Microcirculation (Microvascular Angina or Syndrome X): Diagnosis by Combined Atrial Pacing and Thallium 201 Imaging A Case Report Angiology, August 1, 1990; 41(8): 667 - 672. [Abstract] [PDF] |
||||
![]() |
R. B. Bestetti, L. Z. Pinto, L. A. Finzi, and A. L. Secches Impending Myocardial Infarction in a Patient with Marked Left Ventricular Hypertrophy and Normal Coronary Arteriogram--A Case Report Angiology, November 1, 1989; 40(11): 1020 - 1024. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |